Latest
Milestone Pharmaceuticals enrolls first Canadian patient in AFib Phase 3 trial
The biotech's etripamil nasal spray moves into a 150-patient Phase 3 study for atrial fibrillation with rapid ventricular rate, pursued via a single-study NDA pathway.
Annexon presents vonaprument data at retina meeting
The biotech firm shared results from its Phase 2 and Phase 3 ARCHER programs for vonaprument, an investigational treatment for geographic atrophy, at The Retina Society annual meeting.
Trident Digital Regains Nasdaq Compliance After Market Value Recovery
Singapore-based digital infrastructure firm Trident Digital Tech Holdings exceeded Nasdaq’s $35 million market value threshold for 10 consecutive days, restoring its listing compliance after a prior violation.
MDpanel Appoints Manish Nariwal as COO and Jim Andrews as Chief Client Officer
MDpanel announced the appointment of Manish Nariwal as COO and Jim Andrews as chief client officer to oversee operations and client relations, with both reporting to CEO Jason Erdell.
Nuvectis’ NXP200 gains China breakthrough therapy designation for BRAF-mutant gliomas
Breakthrough Therapy Designation from China’s Center for Drug Evaluation accelerates development of oral BRAF inhibitor for recurrent high-grade gliomas, while Nuvectis plans U.S. IND submission in Q4 2026.
Tvardi reports preclinical STAT3 inhibitor data for colitis
Tvardi Therapeutics published data showing its STAT3 inhibitors prevented colon tumors in a colitis-associated cancer mouse model, bolstering the pipeline ahead of planned GI clinical trials.
Absci Plans Mid-2027 Phase 2 Trial of Endometriosis Drug ABS-201
The clinical-stage biopharmaceutical plans a dose-ranging study of its AI-engineered anti-prolactin receptor antibody in roughly 150 patients.
Researchers propose Zcash-style shielded transactions for Bitcoin without protocol change
A paper from cryptography firm alloc init outlines a Bitcoin privacy layer that stores encrypted transfers on the blockchain but relies on external verification, though it lacks a deposit/withdraw mechanism and faces criticism over fees and trusted setup.
Rockwell Automation Announces Leadership Changes Effective October 1, 2026
The company said Tessa Myers will become senior vice president and chief revenue officer, succeeding Scott Genereux who plans to retire at year‑end 2026. Matt Fordenwalt moves to lead Intelligent Devices and Jordan Reynolds takes over Lifecycle Services.
LightSolver study projects photonic computing acceleration potential
Research shows LightSolver's Laser Processing Unit could accelerate sparse linear solvers by 40 to 80,000 times, depending on the algorithm and problem evaluated.
Elicio to Present Phase 2 Pancreatic Cancer Trial Data at ESMO 2026 Congress
The company will share results from its randomized Phase 2 AMPLIFY-7P study of ELI-002 7P in resected pancreatic cancer, which did not meet the primary disease‑free survival endpoint. Presentation is scheduled for Oct. 23, 2026, at the ESMO Congress in Madrid.
HIFI Secures $37M to Expand Stablecoin Payments and Tokenized Markets
Funding supports infrastructure for cross-border stablecoin transfers and tokenized financial assets, amid growing demand for blockchain-based payment solutions.
Qualcomm Renews Long-Term Patent Deal with Apple
A renewed licensing agreement helps ease Qualcomm’s revenue concerns amid Apple’s push for in-house chip production.
Gold slips below $4,300 as Wall Street and retail sentiment diverge
Spot gold fell to $4,284.97, a 2.17% weekly decline, while a Kitco survey shows a bullish tilt among Wall Street analysts but a stronger bullish bias among retail traders.
EU Delays Vote on Tesla's Supervised Self-Driving System, Next Chance in December
The European Union’s Technical Committee on Motor Vehicles postponed a decision on Tesla’s Full Self‑Driving (Supervised) system from an October 6 vote to its December meeting, leaving approval pending amid mixed national clearance and safety‑data scrutiny.
U.S. and China Reach Preliminary Trade Agreement on Select Goods, Details Due Monday
USTR Jamieson Greer said the two sides have agreed on terms for U.S. agricultural products, medical devices and non‑sensitive Chinese consumer goods, with further specifics slated for release Monday.
1875 Finance appoints Peter Raskin as Director for Zurich Private Banking
Independent wealth manager 1875 Finance announces the appointment of Peter Raskin, former CEO of Berenberg Schweiz and Bergos, to expand its private banking business in Zurich.
Lisata to Present MAR001 Phase 2b Trial Data at AHA Conference
Marea Therapeutics, a Lisata subsidiary, will report late-breaking results from its TYDAL study on ANGPTL4 inhibition at the American Heart Association Scientific Sessions in Chicago.
Collective Metals Appoints Curtis Riou to Board of Directors
The mining exploration firm adds Curtis Riou, a geoscientist with over 25 years in oil, gas and mining, to its board as it advances the Rocas uranium project in Saskatchewan.
Lakewood-Amedex begins Phase 2a trial of Nu-3 gel for diabetic foot ulcers
Lakewood-Amedex Biotherapeutics dosed its first patient in a Phase 2a, single‑blind, dose‑finding study of Nu‑3, a topical antimicrobial gel, in mildly infected diabetic foot ulcers. Topline data are expected in Q1 2027.
HCW Biologics Prices $1.5 Million Private Placement Offering
The company issued 903,614 units at $1.6599 each to an existing stockholder, comprising pre-funded and common warrants, with proceeds earmarked for clinical trials and general corporate purposes.
Lowe’s Begins Drone Delivery Pilot in Matthews, North Carolina
The home‑improvement retailer is testing a drone service with Wing and DoorDash that can deliver small items in as little as 20 minutes from its Matthews store. Eligible products include hand tools, paint, cleaning supplies and batteries.
Mobix Labs Forecasts Q4 Revenue Above Guidance Midpoint
The Irvine-based electronic components maker expects fourth-quarter 2026 revenue to exceed $1.6 million, surpassing the midpoint of its prior $1.4‑$1.8 million range, driven by stronger wireless systems and defense demand.
Revvity launches type 1 diabetes screening kit across Europe
The CE-IVDR-certified GSP T1D 3plex kit enables population-wide screening for at-risk children months or years before symptoms appear.